Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Arthur F. Ryan

At a glance: Arthur F. Ryan is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Jul 7, 2026, reported a sale of $130K. On file: 0 purchase lines ($0) and 48 sale lines ($435K).

Disclosed holdings: about $16.1M of REGN stock: 17,303 shares reported on their latest Form 4 (filed Jul 7, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $435K

Arthur F. Ryan's InsiderPrint

48 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Arthur F. Ryan: 48 trades, 2026 to 20262026: 0 buys, 48 sales

Reading this print: Almost only sells, trading about 48 times a year, typically $4K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (48)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Mark A. Welsh IIIDirector · NOC · 100% match
  2. Kevin RubinCFO · ZS · 99% match
  3. Eynav AzariaSee Remarks · KLTR · 99% match
  4. Randall MoreadithChief Scientific Officer · SER · 99% match
  5. Francis LaurencioCFO · ATOM · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jul 7SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 20017,303 held (−1%) $650.15 $130K +43.4%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 517,598 held (−0%) $701.76 $4K +32.9%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1517,583 held (−0%) $702.46 $11K +32.8%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2417,559 held (−0%) $703.46 $17K +32.6%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1517,544 held (−0%) $704.28 $11K +32.4%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1417,530 held (−0%) $705.56 $10K +32.2%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 717,523 held (−0%) $706.74 $5K +31.9%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 417,519 held (−0%) $707.40 $3K +31.8%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 617,513 held (−0%) $709.45 $4K +31.4%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,511 held (−0%) $710.87 $1K +31.2%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 517,506 held (−0%) $711.49 $4K +31.1%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,505 held (−0%) $712.09 $712 +31.0%
May 4SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,503 held (−0%) $714.13 $1K +30.6%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,702 held (−0%) $771.32 $771 +20.9%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 317,699 held (−0%) $772.76 $2K +20.7%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 817,691 held (−0%) $773.59 $6K +20.5%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 817,683 held (−0%) $774.58 $6K +20.4%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1417,669 held (−0%) $775.58 $11K +20.2%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1317,656 held (−0%) $776.62 $10K +20.1%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 917,647 held (−0%) $777.42 $7K +20.0%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 417,643 held (−0%) $778.24 $3K +19.8%
Apr 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 4017,603 held (−0%) $779.71 $31K +19.6%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 717,796 held (−0%) $777.46 $5K +19.9%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,794 held (−0%) $778.30 $2K +19.8%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 517,789 held (−0%) $779.69 $4K +19.6%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 317,786 held (−0%) $780.69 $2K +19.5%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,784 held (−0%) $781.21 $2K +19.4%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,782 held (−0%) $782.62 $2K +19.2%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1017,772 held (−0%) $783.62 $8K +19.0%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 917,763 held (−0%) $784.48 $7K +18.9%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1117,752 held (−0%) $785.48 $9K +18.7%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 717,745 held (−0%) $786.61 $6K +18.6%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,743 held (−0%) $787.34 $2K +18.4%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2017,723 held (−0%) $788.96 $16K +18.2%
Mar 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 2017,703 held (−0%) $789.28 $16K +18.2%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,902 held (−0%) $775.63 $776 +20.2%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1017,892 held (−0%) $776.59 $8K +20.1%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 5717,835 held (−0%) $777.56 $44K +19.9%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 1217,823 held (−0%) $778.53 $9K +19.8%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 517,818 held (−0%) $779.41 $4K +19.6%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,817 held (−0%) $780.09 $780 +19.5%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 517,812 held (−0%) $781.48 $4K +19.3%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,811 held (−0%) $782.53 $783 +19.2%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 317,808 held (−0%) $783.34 $2K +19.0%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,807 held (−0%) $784.59 $785 +18.9%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,806 held (−0%) $785.71 $786 +18.7%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 217,804 held (−0%) $786.29 $2K +18.6%
Feb 11SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 117,803 held (−0%) $787.82 $788 +18.4%
  • Sell

    Director Arthur F Ryan sold $130K of REGN at $650.15 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Arthur F Ryan sold $4K of REGN at $701.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Arthur F Ryan sold $11K of REGN at $702.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Arthur F Ryan sold $17K of REGN at $703.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Arthur F Ryan sold $11K of REGN at $704.28 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Arthur F Ryan sold $10K of REGN at $705.56 — pre-scheduled 10b5-1 plan sale.

Follow Arthur F. Ryan

Get one email when Arthur F. Ryan files a new purchase or sale. Free.

At most one email a day about Arthur F. Ryan, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.